Tarodyn
Tarodyn Brand names, Tarodyn Analogs
Tarodyn Brand Names Mixture
- No information avaliable
Tarodyn Chemical_Formula
C19H28NO3+
Tarodyn RX_link
http://www.rxlist.com/cgi/generic3/glycopyrrolate.htm
Tarodyn fda sheet
Tarodyn msds (material safety sheet)
Tarodyn Synthesis Reference
No information avaliable
Tarodyn Molecular Weight
318.431 g/mol
Tarodyn Melting Point
192.5 oC
Tarodyn H2O Solubility
No information avaliable
Tarodyn State
Solid
Tarodyn LogP
-0.99
Tarodyn Dosage Forms
Liquid; Tablet
Tarodyn Indication
For use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions, to reduce the volume and free acidity of gastric secretions and to block cardiac vagal inhibitory reflexes during induction of anesthesia and intubation.
Tarodyn Pharmacology
Glycopyrrolate decreases acid secretion in the stomach. Hence it can be used for treating ulcers in the stomach and small intestine, in combination with other medications. In anesthesia, glycopyrrolate injection serves as a preoperative antimuscarinic operation that reduces salivary, tracheobronchial, and pharyngeal secretions, as well as decreases the acidity of gastric secretions blocks cardiac vagal inhibitory reflexes during intubation
Tarodyn Absorption
Rapidly absorbed (1-2 minutes) after intravenous injection
Tarodyn side effects and Toxicity
Side effects include dry mouth, difficult urinating, heachaches, diarrhea and constipation. The medication also induces drowsiness or blurred vision. LD50=709 mg/kg (rat, oral).
Tarodyn Patient Information
No information avaliable
Tarodyn Organisms Affected
Humans and other mammals
